Sherwin Sattarzadeh
Chief Operating Officer, Damora Therapeutics, Inc.
Companies
- Damora Therapeutics, Inc.Chief operating officer Jan 26, 2026 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Damora Therapeutics, Inc. DMRA190,376 shares2$3.5M at $18.32Jan 5, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 5, 2026Granted 190,376 shares of Damora Therapeutics, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2